Loading...

Kathleen Orrico, PharmD

TitleAssociate Clinical Professor
InstitutionUniversity of California San Francisco
DepartmentClinical Pharmacy
Address
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    UCSF School of Pharmacy2007  - 2013“Apples for Preceptors”
    UCSF School of Pharmacy2008  - 2008Long's Teaching Award
    UCSF School of Pharmacy2015  - 2015Long's Teaching Award
    UCSF2016  - 2017Advisor of the Year – Community Outreach Student Alliance

    Collapse Overview 
    Collapse Overview
    Kathleen B. Orrico, PharmD, BCPS is a Health Sciences Associate Professor of Clinical Pharmacy at the University of California, San Francisco School of Pharmacy. She practices as a Clinical Pharmacist at the Palo Alto Medical Foundation where her focus is on drug safety surveillance and medical group quality assurance. She has practiced as a pediatric hospital pharmacist, a drug education coordinator, and as a clinical operations manager. Kathy is a graduate of the University of Michigan and holds a Certificate in Purchasing Management from UC Berkeley. In addition, she is a Board Certified Pharmacotherapy Specialist.


    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse Featured Presentations

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):126-34. PMID: 26812933.
      View in: PubMed
    2. Orrico KB, Huynh MH, Olson CW. Comparison of Glucose Measures in Patients Receiving Concomitant Paroxetine and Pravastatin to Other SSRI/Statin Combinations. Ann Pharmacother. 2014 Sep; 48(9):1172-1176. PMID: 24928102.
      View in: PubMed
    3. Orrico KB. Caring for visually impaired patients. J Am Pharm Assoc (2003). 2013 May-Jun; 53(3):e142-50. PMID: 23699685.
      View in: PubMed
    4. Orrico KB, Wu M, Wilson AR. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting. J Manag Care Pharm. 2011 Nov; 17(9):695-700. PMID: 22050394.
      View in: PubMed
    5. Orrico KB, Lin JK, Wei A, Yue H. Clinical consequences of disseminating the rosiglitazone FDA safety warning. Am J Manag Care. 2010 May 01; 16(5):e111-6. PMID: 20455636.
      View in: PubMed
    6. Orrico KB. Sources and types of discrepancies between electronic medical records and actual outpatient medication use. J Manag Care Pharm. 2008 Sep; 14(7):626-31. PMID: 18774872.
      View in: PubMed
    Kathleen's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (59) concept(s)
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑